| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 6279701 | Neuroscience Letters | 2016 | 15 Pages |
Abstract
In conclusion, our comprehensive meta-analysis indicated that P86L polymorphism is significantly associated with an increased risk for AD. Our data suggest that CALHM1 polymorphism may be potential biomarker in patients with AD.
Keywords
Related Topics
Life Sciences
Neuroscience
Neuroscience (General)
Authors
Myung-Jin Mun, Jin-Ho Kim, Ji-Young Choi, Won-Cheoul Jang,